Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
4 Journal of Cellular and Molecular MedicineFOXO4 peptide targets myofibroblasts and ameliorates bleomycin-induced pulmonary fibrosis in mice (preclinical senolytic model)
Higher quality products with third-party testing and certificates of analysis generally cost more but provide better assurance of purity and potency
The form of B12 in the compound matters
For licensed medicines, this information is provided in the Summary of Product Characteristics (SmPC)
The compound is derived from a sequence associated with gastric protective proteins, which has made it a subject of interest across a broad range of preclinical research models
Another study noted that MOTS-c improved muscle insulin sensitivity and prevented weight gain in mice fed a high-fat diet
US$ 29.95
US$ 23.77
US$ 27.60
US$ 22.30
US$ 28.43
US$ 21.40
US$ 23.28
